Digital therapeutics pioneer Akili Interactive plans to go public in mid-2022 at a $1B valuation

By SharpBrains | January 26, 2022

Pal­i­hapi­tiya-Led SPAC to Merge With Akili in $1 Bil­lion Deal (Bloomberg): Akili Inter­ac­tive, a start­up that has devel­oped a video game to help treat atten­­tion-deficit dis­or­ders in kids, has agreed to go pub­lic through a merg­er with one of Chamath Palihapitiya’s blank-check com­pa­nies. The deal, which con­firms a Bloomberg News report, val­ues the com­bined entity…

Read More

Lyra Health, Big Health and Mantra Health raise a combined $332M to commercialize digital therapeutics for mental/ behavioral health

By SharpBrains | January 20, 2022

Lyra Health scores $235M and buys employ­ee assis­tant pro­gram ICAS World (Mobi­Health News): Employ­er-focused dig­i­tal men­tal health provider Lyra Health announced a whop­ping $235 mil­lion Series F round led by Drag­oneer. Sales­force Ven­tures and Coat­ue also par­tic­i­pat­ed. This new infu­sion of cash brings the com­pa­ny’s total raise to over $900 mil­lion. The fund­ing coin­cid­ed with…

Read More

Update: Why MDMA-assisted psychotherapy may become an FDA-approved treatment for PTSD within 2 years

By SharpBrains | December 30, 2021

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, shar­ing impor­tant brain/ men­tal health news plus a few fun opti­cal illu­sions to tease and appre­ci­ate our unique human minds. #1. Why MDMA-assist­ed psy­chother­a­py may become an FDA-approved treat­ment for PTSD with­in 2 years “We are a phar­ma­cist and physi­cian team who inves­ti­gate the ben­e­fits and harms asso­ci­at­ed with…

Read More

Could I be wrong? Exploring cognitive bias, curiosity, intellectual humility, and lifelong learning

By SharpBrains | November 30, 2021

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing eight time­ly sci­en­tif­ic and indus­try news plus a few fun teasers to appre­ci­ate our unique human brains. #1. Could I be wrong? Explor­ing research on cog­ni­tive bias, curios­i­ty, intel­lec­tu­al humil­i­ty, and life­long learn­ing “None of us thinks that our beliefs and atti­tudes are incor­rect; if we…

Read More

The American Medical Association’s (AMA) to ease access to remote Cognitive Behavioral Therapy Monitoring

By SharpBrains | November 8, 2021

The Dig­i­tal Ther­a­peu­tics Alliance Wel­comes Deci­sion by the CPT® Edi­to­r­i­al Pan­el to Clar­i­fy Report­ing of Remote Cog­ni­tive Behav­ioral Ther­a­py Mon­i­tor­ing Ser­vices (press release): As the lead­ing inter­na­tion­al orga­ni­za­tion on dig­i­tal ther­a­peu­tic thought lead­er­ship and edu­ca­tion, the Dig­i­tal Ther­a­peu­tics Alliance (DTA) wel­comes the Amer­i­can Med­ical Association’s (AMA) Cur­rent Pro­ce­dur­al Ter­mi­nol­o­gy (CPT®) Edi­to­r­i­al Pan­el’s recent deci­sion to…

Read More

Click Therapeutics raises further $52M to build up digital therapeutics pipeline for depression, insomnia, smoking cessation and more

By SharpBrains | November 4, 2021

With Sanofi still on board, Click Ther­a­peu­tics clos­es $52M series B for dig­i­tal ther­a­peu­tics in depres­sion, chron­ic pain and more (Fierce Biotech): Anoth­er medtech devel­op­er’s plans to cre­ate dig­i­tal ther­a­peu­tics to treat a wide range of ill­ness­es are click­ing into place, thanks to a third mul­ti­mil­lion-dol­lar invest­ment in Click Ther­a­peu­tics in bare­ly a year.

Read More